Pemmaraju N, Herling M, Sweet KL, Stein AS, Vasu S, Rosenblat TL, Rizzieri DA, Papayannidis C, Wang ES, Konopleva M, Zuurman M, Tosolini A, Qazilbash M, Lane AA. First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness level. haematol [Internet]. 2026Jul.1 [cited 2026Jul.28];111(7):2508-13. Available from: https://haematologica.org/article/view/13101